WuXi Celebrates Partnerships & Innovation During BIO 2017 Cruise Around San Diego Bay

WuXi celebrated global innovation with hundreds of leaders from biotech, pharma, research institutions, and the venture capital community who attended BIO 2017 during a private cruise reception around San Diego Bay on...

WuXi AppTec Lab Testing Division’s Bioanalytical Service Unit Passed FDA Inspection

We are pleased to announce that WuXi’s  Lab Testing Division(LTD)’s Bioanalytical facility in Shanghai once again passed US FDA’s bioequivalence (BE) inspection with no 483 observations. The inspectors from FDA thoroughly audited...

WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

We are pleased to announce that WuXi Biologics  has received the 2017 Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC, a leading consulting firm. WuXi Biologics has been recognized for its outstanding performance for...

Industry Leaders Give Global Glimpse Inside Israel’s Thriving Life Science Community During WuXi Executive...

More than 100 industry leaders, entrepreneurs and investors gathered during the WuXi Executive Luncheon at MIXiii BIOMED 2017 on May 24. The event included a thought-provoking panel discussion on the growth,...

WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

We are excited to announce that WuXi has acquired HD Biosciences (HDB), a leading biology focused preclinical drug discovery contract research organization (CRO). After completion of acquisition, HD Biosciences will become...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Game Changer: Scientist Mark Waller Ready to “Go” to Next level...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx)   Renowned chemist and computational scientist Mark Waller is ready to go to the next...